Neudle.com: multiple sclerosis early treatment

Differential
(Click to cross reference)

abscess, intracerebral

acute disseminated encephalomyelitis

adverse drug reaction

Alzheimer's disease

Alzheimer's disease, diagnosis of

Alzheimer's disease, preclinical

amyloid beta protein

amyloid imaging

amyloid plaques

angiitis, isolated of CNS

anti MAG antibodies

antibodies to myelin basic protein

antimyelin antibodies

Barkhof MR criteria for MS

brainstem, infarction of

brainstem, lesion of

carcinoma

carcinoma of breast

carotid artery occlusion, intracranial

CAT scan

CAT scan, abnormal

CAT scan, cerebrovascular disease

CAT scan, dense artery sign

CAT scan, early changes in CVA

CAT scan, emission

CAT scan, emission, abnormal

CAT scan, mass effect on

CAT scan, ring sign

central nervous system, infection of

cerebellar infarction

cerebellar lesion

cerebral arteries

cerebral infarction

cerebral infarction, hemorrhagic

cerebral ischemia

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, biochemical markers of CNS disease

cerebrospinal fluid, oligoclonal IgG in

cerebrospinal fluid, protein of

cerebrovascular accident

cerebrovascular accident, acute management of

cerebrovascular accident, arterial occlusion, location

cerebrovascular accident, prognosis in

cerebrovascular accident, recurrent

cerebrovascular accident, severity

cerebrovascular accident, thrombolytic agents in treatment

cerebrovascular accident, volume

cerebrovascular accident, work up for

cerebrovascular accident, young adult

children

Clinical Pathologic Conference(C.P.C.)

cognition

complications

controversies in neurology

cop 1

corneal dystrophy

corpus callosum

corpus callosum, lesion of

cyclophosphamide

degenerative diseases of CNS

dementia

dementia, diagnostic evaluation of

dementia, early detection

dementia, presenile

dementia, rapidly progressive

dementia, screening for

demyelinating disease

diabetes insipidus

diagnostic criteria

differential diagnosis

disability rating scale, neurological

disability, neurological

disease modifying agents

efficacy

encephalitis

encephalitis, viral

encephalomyelitis, postinfectious

encephalopathy, Hashimoto's

encephalopathy, metabolic

fibrinolytic agents, complications

fingolimod

florbetapir

flu-like illness

fourth ventricle, shift of

fumarate

gadolinium

gait disorder

gammaglobulin therapy, intravenous

genetic neurologic disorders

head injury

hearing loss

hearing loss, sudden, unilateral

hemiparesis

heralding manifestation

herpes simplex encephalitis

herpes virus

herpes virus infection

hippocampal atrophy

hippocampus

hydrocephalus

hydrocephalus, exvacuo

hypertension

immunomodulation

immunosuppressive agents

internal carotid artery

intracerebral hemorrhage

intravenous

ischemic penumbra

Jakob-Creutzfeldt disease

liver function enzymes

lobar atrophy

Marburg's disease

McDonald criteria for MS

medulla oblongata, infarction of

memory, impairment of

mild cognitive impairment

misdiagnosis

mitoxantrone

monoclonal antibodies

MRI, cerebrovascular disease

MRI, contrast enhanced

MRI, demyelinating disease

MRI, diffusion weighted

MRI, early changes in CVA

MRI, false negative

MRI, fast

MRI, field strength

MRI, field strength, high

MRI, functional

MRI, incidental finding

multiple sclerosis, acute

multiple sclerosis, asymptomatic

multiple sclerosis, children

multiple sclerosis, chronic progressive

multiple sclerosis, clinical patterns

multiple sclerosis, conversion to clinically definite

multiple sclerosis, diagnosis of

multiple sclerosis, diagnostic criteria

multiple sclerosis, differential diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, early onset

multiple sclerosis, etiology of

multiple sclerosis, misdiagnosis

multiple sclerosis, monosymptomatic

multiple sclerosis, MRI conversion

multiple sclerosis, MRI criteria

multiple sclerosis, pathogenesis

multiple sclerosis, preclinical

multiple sclerosis, presenting manifestations

multiple sclerosis, prognosis

multiple sclerosis, prophylaxsis

multiple sclerosis, radiologically isolated syndrome

multiple sclerosis, relapsing

multiple sclerosis, risk factors for

multiple sclerosis, secondary progressive

multiple sclerosis, spinal form

multiple sclerosis, treatment of

multiple sclerosis, treatment of, first attack

N-acetyl-L-aspartic acid

natalizumab

neoplasm, intracranial

neoplasm, primary intracerebral

neoplasm, primary intracranial

neoplasm, primary of CNS

neoplasm, primary of CNS-children

neurologic disease, diagnoses of

neurologic signs

neurologic symptoms

neuropathology

neuroprotective agents

old age, neurology of

optic nerve, lesion of

optic neuritis

optic neuritis, bilateral

optic neuritis, children

optic neuritis, etiology of

optic neuritis, recurrent

optic neuritis, treatment of

optical coherence tomography

Parkinson disease

Parkinson disease, late onset

Parkinson disease, treatment of

Parkinson disease, young onset

periventricular leukomalacia

Pittsburgh Compound B

placebo

pons, infarction of

posterior cerebral artery territory infarction

posterior fossa

posterior fossa, lesion of

practice guidelines

preclinical

pregnancy, neurologic complications in

prevention of neurologic disorders

prion disease

prognosis

progressive neurologic disorder

protein 14-3-3, cerebrospinal fluid

pseudotumor

rapidly progressing neurologic illness

remote effect of cancer on the nervous system

revascularization, surgical

sensorineural hearing loss

serologic testing

single photon emission computed tomography

slurred speech

somnambulism

spinal cord

spinal cord, enlargement

spinal cord, intramedullary cyst of

spinal cord, lesion of

spinal cord, neoplasm

spinal cord, neoplasm, infants and children

steroid

steroid therapy, CNS treatment and complications with

stroke disability scale

symmetric brain lesions

symptomatic

syphilis, diagnosis and treatment

syphilis, neurologic complications with

syringomyelia

T lesion of MCA-ICA

temporal lobe, atrophy

thyroiditis

tinnitus

tissue plasminogen activator, intravenous

toxic encephalopathy

transient ischemic attack

treatment of neurologic disorder

uremia

urinary incontinence

urinary retention

ventricular enlargement

vertebral-basilar insufficiency

viral infection, reactivation

visual evoked response

West Nile fever

white matter disease

white matter disease, periventricular

Showing articles 1000 to 1050 of 4362 << Previous Next >>

Serial MRI Studies in Pathologically Verified Balo's Concentric Sclerosis
J Comput Assist Tomogr 20:732-735, Chen,C-J.,et al, 1996

Acute Stroke with Atrial Fibrillation:The Copenhagen Stroke Study
Stroke 27:1765-1769, Jorgensen,H.S.,et al, 1996

Stroke Severity in Atrial Fibrillation:The Framingham Study
Stroke 27:1760-1764, Lin,H.J.,et al, 1996

Clinicopath Conf
Demyelinating Disease, Case 8-1996, NEJM 334:715-720996., , 1996

Cerebrospinal Fluid in Acute Optic Neuritis:Experience of the Optic Neuritis Treatment Trial
Neurol 46:368-372, Rolak,L.A.,et al, 1996

Comparison of Triple Dose vs Std Dose Gadolinium-DTPA for Detect of MRI Enhanc Lesions in Pts with MS
Neurol 46:379-384, Filippi,M.,et al, 1996

Serial Gadolinium-Enhanced MRI of the Brain and Spinal Cord in Early Relapsing-Remitting MS
Neurol 46:373-378, Thorpe,J.W.,et al, 1996

Surgery for Seizures
NEJM 334:647-652, Engel,J.Jr., 1996

Evidence for Genetic Basis of Multiple Sclerosis
Lancet 347:1728-1730, Sadovnick,A.D.,et al, 1996

Clinical and Subclinical Neurological Involvement in Children of Conjugal Multiple Sclerosis Patients
Multiple Sclerosis 1:170-172, Constantinescu,C.S.,et al, 1996

Conduction Aphasia in Multiple Sclerosis:A Case Report with MRI Findings
Neurol 47:576-578, Arnett,P.A.,et al, 1996

Multiple Sclerosis of the Spinal Cord:Magnetic Resonance Appearance
J Comput Assist Tomogr 20:434-438, Thielan,K.R.&Miller,G.M., 1996

Sporadic Corticosteroid Pulses and Osteoporosis in Multiple Sclerosis
Arch Neurol 53:753-757, Schwid,S.R.,et al, 1996

Impact of Aerobic Training on Fitness and Quality of Life in Multiple Sclerosis
Ann Neurol 39:432-441, 4221996., Petajan,J.H.,et al, 1996

Low Body Weight in Alzheimer's Disease is Associated with Mesial Temporal Cortex Atrophy
Neurol 46:1585-1591, Grundman,M.,et al, 1996

Risk of Cancer from Azathioprine Therapy in Multiple Sclerosis:A Case-Control Study
Neurol 46:1607-1612, Confavreux,C.,et al, 1996

Palliative Care in Neurology
Neurol 46:870-872, 5981996., Bernat,J.L.,et al, 1996

Problems with Myofascial Pain Syndrome and Fibromyalgia Syndrome
Neurol 46:593-597, Bohr,T., 1996

Treatment of Secondary Progressive Multiple Sclerosis with the Immunomodulator Linomide:Study with Monthly MRI Evaluation
Neurol 47:341-346, Karussis,D.M.,et al, 1996

Pure Motor Hand Weakness
Semin Neurol 16:75-81, Lewis,R.A., 1996

Lyme Radiculoneuritis Treated with Intravenous Immunoglobin
Neurol 46:1174-1175, Crisp,D.&Ashby,P., 1996

Is Chronic Respiratory Failure in Neuromuscular Diseases Worth Treating
JNNP 61:1-3, Shneerson,J.M., 1996

Congenital Muscular Dystrophy Syndromes Distinguished by Alkaline and Acid Phosphatase, Merosin, & Dystrophin Staining
Neurol 46:810-814, Connolly,A.M.,et al, 1996

Refractory Epilepsy:Comparison of MR Imaging, CT, and Histopathologic Findings in 117 Patients
Radiology 201:97-105, Bronen,R.A.,et al, 1996

Bilateral Ptosis Due to Mesencephalic Lesions with Relative Preservation of Ocular Motility
J Neuro-Ophthalmol 16:258-263, Martin,T.J.,et al, 1996

Periodic Lateralized Epileptiform Discharges in Multiple Sclerosis
Electroenceph Clin Neurophysiol 98:5-8, Shabolla,D.R.,et al, 1996

A Study of Oligoclonal Band Negative Multiple Sclerosis
JNNP 60:28-30, Zeman,A.Z.J.,et al, 1996

Management of Patients Receiving Interferon Beta-1b for MS:Report of a Consensus Conf
Neurol 46:12-18, Lublin,F.D.,et al, 1996

Herpes Simplex Virus in Postmortem Multiple Sclerosis Brain Tissue
Arch Neurol 53:125-133, 1231996., Sanders,V.J.,et al, 1996

Gait Disorders in Older Adults
J Am Geriatr Soc 44:434-452, Alexander,N.B., 1996

Isolated Body Lateropulsion Caused by a Lesion of the Cerebellar Peduncles
JNNP 60:356-357, Bertholon,P.,et al, 1996

Fatigue Therapy in Multiple Sclerosis:A Double-blind, Randomized, Parallel Trial of Amantadine, Pemoline & Placebo
Neurol 45:1956-1961, Krupp,L.B.,et al, 1995

Cerebrospinal Fluid
JNNP 59:349-357, Thompson,E.J., 1995

Central Nervous System Disease in a Child with Primary Sjogren Syndrome
J Pediatr 127:961-963, Ohtsuka,T.,et al, 1995

Intractable Hiccups:The Role of Cerebral MR in Cases Without Systemic Cause
AJNR 16:2093-2100, Marsot-Dupuch,K.,et al, 1995

Campylobacter Jejuni Infection and Guillain-Barre Syndrome
NEJM 333:1374-1379, 14151995., Rees,J.H.,et al, 1995

Measuring Patient-Centered Outcomes in Neurologic Disease, Extending the Q-TWIST Method
Arch Neurol 52:754-762, Schwartz,C.,et al, 1995

Mild Traumatic Brain Injury:Pathophysiology, Natural History, and Clinical Management
Neurol 45:1253-1260, 12511995., Alexander,M.P., 1995

Adverse Outcomes of Bacterial meningitis in School-Age Survivors
Pediatrics 95:646-655, Grimwood,K.,et al, 1995

The Eosinophilia-Myalgia Syndrome:Status of 205 Patients and Results of Treatment 2 Years After Onset
Ann Int Med 122:851-855, Hertzman,P.A.,et al, 1995

Reflex Sympathetic Dystrophy
BMJ 310:1645-1648, Paice,E., 1995

Multifocal Motor Neuropathy with Conduction Block:A Study of 24 Patients
JNNP 59:38-44, Bouche,P.,et al, 1995

Surgical Treatment of Temporal Lobe Epilepsy:Clinical, Radiological and Histopathological Findings in 178 Patients
JNNP 58:666-673, Zentner,J.,et al, 1995

Complex Partial Status Epilepticus Accompanied by Serious Morbidity and Mortality
Neurol 45:1499-1504, Krumholz,A.,et al, 1995

Bilaterally Symmetric Hippocampi and Surgical Outcome, Jack
Neurol 45:1353-1358, Jr,C.R.,et al, 1995

Hippocampal Volumetrics Differentiate Pts with Temporal Lobe Epilepsy & Extratemporal Lobe Epil
Arch Neurol 52:819-824, Gilmore,R.L.,et al, 1995

Preoperative MRI Predicts Outcome of Temporal Lobectomy:An Actuarial Analysis
Neurol 45:1358-1363, 12481995., Berkovic,S.F.,et al, 1995

Prediction of Long-Term Outcome in the Early Hours Following Acute Ischemic Stroke
Arch Neurol 52:250-255, Fiorelli,M.,et al, 1995

The Interferons:Biological Effects, Mechanisms of Action, and Use in Multiple Sclerosis
Ann Neurol 37:7-15, Weinstock-Guttman,B.,et al, 1995

New Treatments for Multiple Sclerosis
BMJ 310:345-346, McDonald,W.I., 1995

Showing articles 1000 to 1050 of 4362 << Previous Next >>